Cargando…

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

Introduction: Pembrolizumab demonstrated promising results in hypermutated tumors of diverse origin. Immunohistochemical loss of mismatch repair (MMR) proteins has been suggested as a surrogate of hypermutation in high-grade gliomas (HGG). We evaluated the efficacy and safety of pembrolizumab in rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Giuseppe, Barresi, Valeria, Indraccolo, Stefano, Simbolo, Michele, Fassan, Matteo, Mandruzzato, Susanna, Simonelli, Matteo, Caccese, Mario, Pizzi, Marco, Fassina, Arianna, Padovan, Marta, Masetto, Elena, Gardiman, Marina Paola, Bonavina, Maria Giuseppina, Caffo, Maria, Persico, Pasquale, Chioffi, Franco, Denaro, Luca, Dei Tos, Angelo Paolo, Scarpa, Aldo, Zagonel, Vittorina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464918/ https://www.ncbi.nlm.nih.gov/pubmed/32823925 http://dx.doi.org/10.3390/cancers12082283

Ejemplares similares

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study
por: Caccese, Mario, et al.
Publicado: (2020)

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
por: Lombardi, Giuseppe, et al.
Publicado: (2021)

Intraventricular Meningiomas: Clinical-Pathological and Genetic Features of a Monocentric Series
por: Ammendola, Serena, et al.
Publicado: (2022)

The role of radiation therapy and systemic treatments in meningioma: The present and the future
por: Caccese, Mario, et al.
Publicado: (2023)

Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review
por: Baro, Valentina, et al.
Publicado: (2022)

Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
por: Padovan, Marta, et al.
Publicado: (2021)

Clinical Management of Diffuse Low-Grade Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Validation of the Comprehensive Geriatric Assessment as a Predictor of Mortality in Elderly Glioblastoma Patients
por: Lombardi, Giuseppe, et al.
Publicado: (2019)

Patterns of gray and white matter functional networks involvement in glioblastoma patients: indirect mapping from clinical MRI scans
por: Sansone, Giulio, et al.
Publicado: (2023)

Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study
por: Caccese, Mario, et al.
Publicado: (2022)

Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk
por: Barresi, Valeria, et al.
Publicado: (2023)

An Overview of Intracranial Ependymomas in Adults
por: Lombardi, Giuseppe, et al.
Publicado: (2021)

Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients
por: Del Bianco, Paola, et al.
Publicado: (2022)

Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy
por: Magri, Sara, et al.
Publicado: (2021)

Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
por: Loupakis, Fotios, et al.
Publicado: (2019)

The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
por: Tizianel, Irene, et al.
Publicado: (2022)

Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study
por: Parrozzani, Raffaele, et al.
Publicado: (2020)

Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives
por: Birzu, Cristina, et al.
Publicado: (2020)

DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
por: Simbolo, Michele, et al.
Publicado: (2013)

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free Survival
por: Barresi, Valeria, et al.
Publicado: (2021)

Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients
por: Giunco, S., et al.
Publicado: (2023)

Mesenchymal tumours of the gastrointestinal tract
por: Sbaraglia, Marta, et al.
Publicado: (2021)

Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges
por: Scarmozzino, Federico, et al.
Publicado: (2023)

Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment
por: Barresi, Valeria, et al.
Publicado: (2019)

Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
por: Gkountakos, Anastasios, et al.
Publicado: (2023)

PET/MR in recurrent glioblastoma patients treated with regorafenib: [(18)F]FET and DWI-ADC for response assessment and survival prediction
por: Lombardi, Giuseppe, et al.
Publicado: (2022)

Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study
por: Caccese, Mario, et al.
Publicado: (2023)

Bone metastases from neuroendocrine tumors: clinical and biological considerations
por: Scopel, Matteo, et al.
Publicado: (2022)

Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
por: Perilli, Lisa, et al.
Publicado: (2014)

Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study
por: Olioso, Debora, et al.
Publicado: (2021)

Triumphs and tribulations of COVID-19 vaccines: Lessons to be learned from smallpox epidemics in the 1700s
por: Fassina, Ambrogio, et al.
Publicado: (2021)

Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care
por: Ruggiero, Elena, et al.
Publicado: (2022)

An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
por: Bevere, Michele, et al.
Publicado: (2023)

Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair–deficient metastatic colorectal cancer: Immunological and molecular profiling
por: Bergamo, Francesca, et al.
Publicado: (2022)

pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells
por: Barresi, Valeria, et al.
Publicado: (2022)

High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients
por: Marino, Dario, et al.
Publicado: (2022)

Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
por: Pellino, Antonio, et al.
Publicado: (2019)

Multifocal Medulloblastoma in an Adult Patient: Description of a Rare Presentation and Review of the Literature
por: Troncon, Irene, et al.
Publicado: (2020)

Immunotherapy in Gastrointestinal Cancers
por: Procaccio, Letizia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sp5u2b3jd5eptjrc5b7h74qc3e